elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37443603-096100F4-7A93-4C52-9CE9-990A1DABFA1F
Q37443603-096100F4-7A93-4C52-9CE9-990A1DABFA1F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37443603-096100F4-7A93-4C52-9CE9-990A1DABFA1F
Combining T-cell immunotherapy and anti-androgen therapy for prostate cancer.
P2860
Q37443603-096100F4-7A93-4C52-9CE9-990A1DABFA1F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37443603-096100F4-7A93-4C52-9CE9-990A1DABFA1F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e5c425082bb14976dad61d05ee7d8a72d9073a5d
P2860
Promising tumor-associated antigens for future prostate cancer therapy.